PPC
MRK icon

Pennington Partners & Co’s Merck MRK Stock Holding History

Pennington Partners & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Buy
2,628
+270
+11% +$31.2K 0.11% 91
2025
Q4 		$250K Buy
+2,358
New +$221K 0.1% 82
2025
Q2 		– Sell
-2,511
Closed -$227K – 87
2025
Q1 		$227K Sell
2,511
-932
-27% -$87K 0.13% 70
2024
Q4 		$345K Buy
+3,443
New +$355K 0.17% 61

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pennington Partners & Co's MRK Position: Q1 2026 in Review

Pennington Partners & Co increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $31.2K and bringing the position to 2,628 shares worth $318K. The position accounts for 0.11% of the portfolio, ranked #91.

Pennington Partners & Co first reported a position in MRK in Q4 2024 and has held it in 4 quarters since. The position peaked at $345K in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pennington Partners & Co held 2,628 shares of Merck worth $318K as of Q1 2026.
  • Pennington Partners & Co bought 270 Merck shares in Q1 2026, an estimated $31.2K.
  • Merck made up 0.11% of Pennington Partners & Co's portfolio in Q1 2026, its #91 holding.
  • Pennington Partners & Co first reported a position in Merck in Q4 2024 and has held it in 4 quarters since.
  • Pennington Partners & Co's Merck position peaked at $345K in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pennington Partners & Co's 13F filing for Q1 2026, filed 14 May 2026.